Form D · Other Health Care
Endolynx Inc.
Jersey City, NJ · CIK 0001967540
Offering snapshot reported Mar 6, 2023 · SEC filing
- Reported sold
- $30K Offering amount: $30K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 4, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2023 | Initial | $30,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-474945
Source: Form D, filed Mar 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Felek Jachimowicz | Director, Executive |
| Robert Jenkins | Director, Executive |
| David Schaner | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
77 Hudson Street Apt 3303
Jersey City, NJ, 07302
Jersey City, NJ, 07302